Draw slowly
In this cohort study, the use of GLP-1RAs, particularly semaglutide and tirzepatide, is associated with a lower incidence of dementia, stroke, and all-cause mortality in patients with both type 2 diabetes and obesity, suggesting potential neuroprotective and cerebrovascular benefits, Huan-Tang Lin, MD, PhD, and colleagues concluded
How long do you have to take semaglutide to see results
These decisions should always involve your prescribing provider, as drug interactions and compounded side effects require professional evaluation
Your go-to breakfasts and snacks are no longer effective
This dual-action is what sets tirzepatide apart, making it a compelling alternative for those not achieving desired results with semaglutide